Morgan Stanley’s Mateon Therapeutics, Inc. MATN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,000
Closed -$1K 6651
2016
Q3
$1K Hold
1,000
﹤0.01% 6476
2016
Q2
$1K Buy
+1,000
New +$708 ﹤0.01% 6474

Other funds holding MATN